Dr. Scott Rocklage is a leading chemist, pharmaceutical strategist, inventor and author who has over 30 years of experience in the advanced life science health care industry. Due to his impressive educational credentials, he has achieved a high degree of accomplishment in the field of chemical and medical engineering. His discoveries have facilitated the FDA’s approval of three New Drug treatments (Omniscan™, Teslascan® and Cubicin®). Dr. Rocklage attained his Bachelor’s degree in Chemistry from the University of California, Berkeley and his PhD in Chemistry from the Massachusetts Institute of Technology (MIT) where he performed research in Richard R. Schrock’s lab. Schrock won the 2005 Nobel Prize in Chemistry for developing the metathesis method in organic synthesis. He has 30 U.S. patents for inventions and approximately 100 peer-reviewed articles.
Throughout his vocation, Scott Rocklage has worked for a diverse range of companies in the biotechnology field of industry. As of now, he is the managing partner of 5AM Ventures, an investment firm in California finances early and late stage ventures. They assist companies that are trying to develop innovative solutions in treating healthcare concerns through unconventional ground-breaking scientific technology. Dr. Rocklage worked briefly as the chief executive of EPIRUS Biopharmaceuticals, Inc. in 2016. Before 5AM Ventures, he was employed by Cubist Pharmaceuticals, which was a U.S. biopharmaceutical company that conducted research and development, for commercializing pharmaceutical products. Another company he worked with is Nycomed Salutar, Inc. This is a diagnostic imaging company that creates in-vivo contrast agents to use in magnetic resonance imaging exams. He was CEO of Amersham Health, Chairman of the board at Cidara, Chairman at Nova Therapeutics and Co-President of Ilypsa and Scott’s lacrosse camp.
Dr. Scott’s, as well as 5AM Ventures, great achievements may be attributed to the four fold approach they use in creating innovative solutions. They incorporate financial, legal, medical and scientific knowledge to construct investment prospects and state of the art therapies. His biomedical research and achievements has significantly benefited many and helped to advance the medical community and health care district. Dr. Rocklage has become quite renowned among his biomedical and scientific peers.
Other Reference: http://www.rennovia.com/team/scott-m-rocklage/